Differential RNA display identifies novel genes associated with decreased vitamin D receptor expression

Molecular and Cellular Endocrinology

Volumn 142, Issue 1-2, 1998, Pages 131-139

  Dabrowski, Michal ^b   Robinson, Elaine ^a   V Hughes, Susan ^a   Bland, Rosemary ^a   Hewison, Martin ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

1,25 Dihydroxyvitamin D; 17 hydroxysteroid dehydrogenase type IV; Differential display; DNA protein kinase; Vitamin D receptor

Indexed keywords

COMPLEMENTARY DNA; ESTRADIOL; GENE PRODUCT; MESSENGER RNA; MYC PROTEIN; PROTEIN KINASE; TESTOSTERONE 17BETA DEHYDROGENASE; VITAMIN D RECEPTOR;

ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVE SITE; GENE EXPRESSION; GENE ISOLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

17-HYDROXYSTEROID DEHYDROGENASES; BLOTTING, NORTHERN; CALCITRIOL; CELL DIVISION; DNA, COMPLEMENTARY; ESTRADIOL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES, MYC; HUMANS; ISOENZYMES; MONOCYTES; POLYMERASE CHAIN REACTION; PROTEIN KINASES; RECEPTORS, CALCITRIOL; RNA; RNA, MESSENGER; SEQUENCE ANALYSIS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032566142     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00111-7     Document Type: Article

References (34)

1. Adamski J., Normand T., Leenders F., Monte D., Begue A., Stehelin D., Jungblut P.W., de Launoit Y. Molecular cloning of a novel widely expressed human 80 kDa 17beta-hydroxysteroid dehydrogenase IV. Biochem. J. 311:1995;437-443.
2. Anderson C.W., Lees-Miller S.P. The nuclear serine/threonine protein kinase DNA-PK. Crit. Rev. Euk. Gene Expr. 2:1992;283-314.
3. Arnold S.F., Obourn J.D., Jaffe H., Notides A.C. Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding. J. Steroid Biochem. Mol. Biol. 52:1995;159-171.
4. Blunt T., Gell D., Fox M., Taccioli G.E., Lehmann A.R., Jackson S.P., Jeggo P.A. Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc. Natl. Acad. Sci. USA. 93:1996;10285-10290.
5. 3. Biochem. J. 316:1996;362-371.
6. DeLuca H.F. New concepts of vitamin D functions. Ann. NY Acad. Sci. 669:1992;59-69.
7. Diel P., Walter A., Fritzmeier K.H., Hegele-Hartung C., Knauthe R. Identification of estrogen regulated genes in Fe33 rat hepatoma cells by differential display polymerase chain reaction and their hormonal regulation in rat liver and uterus. J. Steroid Biochem. Mol. Biol. 55:1995;363-373.
8. Hartley K.O., Gell D., Smith G.C.M., Zhang H., Divecha N., Connelly M.A., Admon A., Lees-Miller S.P., Anderson C.W., Jackson S.P. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell. 82:1995;849-856.
9. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., Domingez C.E., Juruthka P.W. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res. 13:1998;325-349.
10. Haussler M.R., Haussler C.A., Jurutka P.W., Thompson P.D., Hsieh J.C., Remus L.S., Selznick S.H., Whitfield G.K. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J. Endocrinol. 154:1997;S57-S73.
11. Hewison M., O'Riordan J.L.H. Vitamin D resistance. Bailliere's Clin. Endocrinol. Metab. 8:1994;305-316.
12. Hewison M., Dabrowski M., Faulkner L., Hughson E., Vadher S., Rut A.R., Brickell P.M., O'Riordan J.L.H., Katz D.R. J. Immunol. 153:1994;5709-5719.
13. Hewison M., Dabrowski M., Vadher S., Faulkner L., Cockerill F.J., Brickell P.M., O'Riordan J.L.H., Katz D.R. Antisense inhibition of vitamin D receptor expression induces apoptosis in monoblastoid U937 cells. J. Immunol. 156:1996;4391-4400.
14. Jacob F., Homann D., Adamski J. Expression and regulation of aromatase and 17 beta-hydroxysteroid dehydrogenase type 4 in human THP 1 leukemia cells. J. Steroid Biochem. Mol. Biol. 55:1995;555-563.
15. 3 regulates c-myc mRNA levels in tonsillar T lymphocytes. Immunology. 74:1991;589-593.
16. 3 receptor gene expression in cultured cells by serum and growth factors. J. Bone Miner. Res. 6:1991;1099-1108.
17. Labhart P. DNA-dependent protein kinase specifically represses promoter-directed transcription initiation by RNA polymerase I. Proc. Natl. Acad. Sci. USA. 92:1995;2934-2938.
18. Leenders F., Tesdorpf J.G., Markus M., Engel T., Seedorf U., Adamski J. Porcine 80-kDa protein reveals intrinsic 17 beta-hydroxysteroid dehydrogenase, fatty acyl-CoA-hydratase/dehydrogenase, and sterol transfer activities. J. Biol. Chem. 271:1996;5438-5442.
19. Liang P., Pardee A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257:1992;967-971.
20. Littlewood T.D., Evan G.I. The role of myc oncogenes in cell growth and differentiation. Adv. Dent. Res. 4:1990;69-79.
21. Luu-The V., Zhang Y., Poirere D., Labrie F. Characteristics of human types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition. J. Steroid Biochem. Mol. Biol. 55:1995;581-587.
22. Matkovits T., Christakos S. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation. Mol. Endocrinol. 9:1995;232-242.
23. Minucci S., Wong J., Blanco J.C., Shi Y.B., Wolffe A.P., Ozato K. Retinoid receptor-induced alteration of the chromatin assembled on a ligand-responsive promoter in Xenopus oocytes. Mol. Endocrinol. 12:1998;315-324.
24. Ozaki K., Kuroki T., Hayashi S., Nakamura Y. Isolation of three testis-specific genes (TSA303, TSA806, TSA903) by a differential mRNA display method. Genomics. 36:1996;316-319.
25. Pearson W.R., Lipman D.J. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. USA. 85:1988;2444-2448.
26. Roth D.B., Lindahl T., Gellert M. Repair and recombination. How to make ends meet. Curr. Biol. 5:1995;496-499.
27. Schulman I.G., Juguilon H., Evans R.M. Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol. Cell. Biol. 16:1996;3807-3813.
28. 3 in HL-60 promyelocytic leukemia cells. J. Biol. Chem. 262:1987;4104-4108.
29. Tremblay G.B., Tremblay A., Labrie F., Giguere V. Ligand-independent activation of the estrogen receptor alpha and beta by mutations of conserved tyrosine can be abolished by antiestrogens. Cancer Res. 58:1998;877-881.
30. Walters M.R. Newly identified actions of the vitamin D endocrine system. Endocr. Rev. 13:1992;719-764.
31. Weigel N.K., Carter T.H., Schrader W.T., O'Malley B.W. Chicken progesterone receptor is phosphorylated by a DNA-dependent protein kinase during in vitro transcription assays. Mol. Endocrinol. 6:1992;8-14.
32. 3 and thyroid hormone in three osteosarcoma cell lines. Endocrinology. 136:1995;4304-4314.
33. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., Kawakami T., Arioka K., Sato H., Uchiyama Y., Masushige S., Fukamizu A., Matsumoto T., Kato S. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 16:1997;391-396.
34. Zhang Y., Word R.A., Fesmire S., Carr B.R., Rainey W.E. Human ovarian expression of 17 beta-hydroxysteroid dehydrogenase types 1, 2, and 3. J. Clin. Endocr. Metab. 81:1996;3594-3598.